Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trivalent reassortant rotavirus vaccine phase 3 efficacy and safety in Chinese infants
CTR20132113Phase 3Completed
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Apr 2014
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine 116E in rotaviral diarrhea, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Apr 2014; status: completed.
02
Drugs
rotavirus vaccine 116E
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on CTR20132113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132113.